What Researchers Did
Researchers evaluated whether HBOT administered before umbilical cord blood stem cell transplantation improved post-transplant recovery in 15 adult patients, comparing transfusion needs and growth factor use to historical controls.
What They Found
HBOT patients achieved red blood cell and platelet independence significantly faster than historical controls. By days 66 and 74, 100% of HBOT patients were independent from blood product transfusions, versus only 67% and 65% of controls by day 100. HBOT patients also required fewer days of growth factor support.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The comparison to historical controls rather than a concurrent randomized group introduces significant selection bias, and the sample of 15 patients is too small to draw definitive conclusions.